Patents by Inventor Martin Schönharting

Martin Schönharting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
    Patent number: 6432968
    Abstract: Xanthines of the formula I are useful in producing a superadditive increase in immunosuppressive action when combined with immunosuppressive compounds such as CysA or FK506.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: August 13, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Martin Schönharting, Ulrich Gebert, Mark Waer
  • Combined preparation for the therapy of immune diseases
    Patent number: 6337325
    Abstract: A combination preparation comprising a compound which has a phosphodiesterase-inhibiting action, and a compound which reduces the biologically effective intracellular Ca2+ content, is suitable for the treatment of immunological diseases.
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: January 8, 2002
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Martin Schönharting, Stefan Müllner, Peter Zabel